Molecular and Immunohistochemical Study of Class I Growth Factor Receptors in Squamous Cell Lung Carcinomas

This publication has 19 references indexed in Scilit:

• C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
  Journal of Clinical Investigation, 1994
• Oncogenes and onco-suppressor genes in lung cancer
  Respiratory Medicine, 1993
• Expression of the ERBB3 gene product in breast cancer
  British Journal of Cancer, 1992
• TheerbB-3 Gene in human pancreatic cancer
  The Journal of Pathology, 1992
• Evidence by In Situ Hybridization that c-erbB-2 Proto-oncogene Expression Is a Marker of Malignancy and Is Expressed in Lung Adenocarcinomas
  American Journal of Respiratory Cell and Molecular Biology, 1992
• Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers
  British Medical Bulletin, 1991
• Metabolism and Effects of Epidermal Growth Factor and Related Growth Factors in Mammals*
  Endocrine Reviews, 1990
• Polymerase chain reaction based assay to detect allelic loss in human DNA: loss of β-interleron gene in chronic myelogeneous leukemia
  Nucleic Acids Research, 1990
• Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
  Proceedings of the National Academy of Sciences, 1989
• Over‐expression of the EGF receptor is a hallmark of squamous cell carcinomas
  The Journal of Pathology, 1986